# Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain

> **NCT00446797** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 278 (actual)

## Conditions studied

- Ankle Sprain

## Interventions

- **DRUG:** Non-selective NSAIDS
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00446797
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446797, "Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00446797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*